TNPSC Thervupettagam

Spinal muscular atrophy

March 4 , 2025 33 days 201 0
  • A two-and-a-half-year-old girl has shown no signs of a genetic disorder — known as spinal muscular atrophy (SMA).
  • This girl was becoming the first person in the world to be treated for the disease while in the womb.
  • The girl’s mother began taking the gene-targeting drug during late pregnancy, and the child continues to take it.
  • SMA is a debilitating genetic condition which affects motor neurons that control movement, and leads to progressive muscle weakening.
  • About one in every 10,000 births have some form of the condition.
  • This was making it a leading genetic cause of death in infants and children.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories